The switch between E-cadherin and N-cadherin, which has been widely used to monitor the progress of EMT, increases BCCs motility and invasiveness [73] that in turn is facilitated by changes in the ECM surrounding tumor cells [74]. The gene discussed is CDH1; the disease is neoplasm.